Search

Saved articles

You have not yet added any article to your bookmarks!

Newsletter image

Subscribe to the Newsletter

Join 10k+ people to get notified about new posts, news and tips.

Do not worry we don't spam!

Hims and Hers Expands Weight-Loss Services to the UK with New Membership Options

Hims and Hers Expands Weight-Loss Services to the UK with New Membership Options

Post by : Saif Rahman

Online telehealth service Hims and Hers Health has announced its expansion into the United Kingdom's weight-loss sector. This initiative represents a significant milestone for the company as it taps into a burgeoning market for medical weight-loss solutions. Previously, Hims and Hers focused on sexual health, skincare, and hair-loss treatments in the UK. With this new offering, the company seeks to cater to a larger audience in search of safe and clinically supervised weight-loss methods.

The new UK program will feature well-known medications such as Wegovy, manufactured by Novo Nordisk, and Mounjaro from Eli Lilly. These treatments have garnered global interest due to their ability to assist individuals in managing weight by regulating appetite and enhancing glucose metabolism. Additionally, Hims and Hers will provide Orlos, a cost-effective, over-the-counter alternative containing orlistat as its active component.

The subscription for the weight-loss plan in the UK will commence at £149 monthly for those committing to a yearlong membership. This model mirrors offerings already in place for Hims in the United States. Clients will first undergo a clinical assessment, and upon approval, will receive a tailored prescription alongside ongoing healthcare support. This approach promotes safe and appropriate use of the medications.

Earlier this year, Hims and Hers bolstered its European presence by acquiring Zava, a London-based telehealth provider that prescribes and distributes weight-loss medications in the UK, Germany, France, and Ireland. This acquisition facilitated the introduction of its popular American-style online healthcare services to European customers.

A key driver of anticipated demand in the UK is the pricing disparity between nations. Weight-loss medications such as Wegovy and Mounjaro are significantly cheaper in the UK, with online pharmacies pricing them between £109 and £149 monthly, whereas these drugs typically range from $199 to $449 monthly in the US. Despite Eli Lilly's recent increase in the list price of Zepbound, UK prices remain lower compared to American costs.

However, the UK’s National Health Service (NHS) faces limitations in providing access due to high demand, costs, and supply shortages. This situation has led many to seek private alternatives. Hims and Hers aims to facilitate access to weight-loss drugs that are often difficult to secure through the NHS due to their online model and competitive pricing.

The company emphasizes that its UK approach prioritizes safety, clinical oversight, and customer convenience. After an online assessment, patients can receive medications via home delivery, supplemented with continuous support to manage side effects, adjust dosages, and track progress. This system intertwines medical guidance with the ease of telehealth solutions.

The debut of these weight-loss treatments in the UK highlights the rapid growth of the weight-loss drug market globally. As more individuals pursue medical solutions for obesity management, companies like Hims and Hers are racing to provide accessible options for well-trusted medications.

Overall, Hims and Hers anticipates that its subscription model, clinical support, and favorable UK pricing will help it appeal to thousands of new clients. As the need for weight-loss medications escalates across the globe, Hims and Hers is strategically positioning itself as a significant contender in this expanding arena.

Dec. 10, 2025 2:31 p.m. 233

#Global News

Klang Flash Floods Disrupt Traffic Across Selangor, Malaysia
Nov. 18, 2026 11:37 a.m.
Heavy rain causes Klang flash floods, disrupting traffic in Bukit Raja and Shah Alam as motorists face delays across Selangor, Malaysia
Read More
Xi Jinping Urges Asia-Pacific Nations to Remove Trade Barriers
Nov. 18, 2026 10:20 a.m.
Xi Jinping urges Asia-Pacific economies to remove trade barriers, boost investment and strengthen regional stability at the APEC Summit in China
Read More
Singapore Reviews New US Chip Export Controls Targeting China
Nov. 17, 2026 11:34 a.m.
Singapore reviews US chip export restrictions targeting China's AI access, raising concerns for semiconductor trade and data centre businesses
Read More
APEC Members Emphasise Safe and Responsible Use of Artificial Intelligence
Nov. 17, 2026 10:24 a.m.
APEC members discuss responsible AI use, digital innovation and data governance as China and the US compete for global AI leadership
Read More
Union of European Clubs Challenge UEFA and EFC Over EU Competition Rules
Nov. 16, 2026 5:18 p.m.
UEC files an EU competition complaint against UEFA and EFC, challenging club representation, governance rights and decision-making powers
Read More
US Dollar Extends Rally as Yen Faces Pressure After Weak GDP
Nov. 16, 2026 4:29 p.m.
The US dollar reaches a 19-month high as traders assess Fed rate signals, weak Japan GDP data and possible yen intervention
Read More
Sheikh Hasina Plans December Return to Bangladesh Despite Death Threat
Nov. 16, 2026 3:35 p.m.
Sheikh Hasina plans to return to Bangladesh in December despite death threats, a death sentence and growing political tensions with Dhaka
Read More
Trump Plans to Name Nvidia and AI Firms US National Champions
Nov. 16, 2026 10:01 a.m.
Trump administration plans to name Nvidia, Amazon, Microsoft and OpenAI among US AI national champions to expand overseas and compete with China
Read More
Mohammed Shami Retires From Test Cricket, Eyes White-Ball Career
Nov. 7, 2026 11:10 a.m.
Mohammed Shami retires from Test cricket after 13 years, with 229 wickets. He will continue playing white-ball cricket and domestic matches
Read More
Trending News